Vectron is your partner for development of robust and cost-efficient microbial protein production processes. Using our proprietary portfolio of expression technologies, we develop bacterial strains that produces your protein at right titers and with right quality.
Location: Norway, Trondheim
Employees: 11-50
Founded date: 2008
Investors 1
Mentions in press and media 2
| Date | Title | Description |
| 30.07.2024 | Microbial Expression Optimization: How E. coli Strain Development Innovations are Shaping the Future of Drug Production, Upcoming Webinar Hosted by Xtalks | In this free webinar, learn about Escherichia coli (E. coli)'s position as the most popular host for recombinant protein production. Attendees will be introduced to the recent advances in the engineering of E. coli for improved recombinant ... |
| 17.06.2021 | Vectron Biosolutions to Boost Protein Production Offering with Acquisition of Secretion Platform from T3S Technologies and $2.7M Series A Financing Round | Trondheim, Norway – June 17, 2021, Vectron Biosolutions, upstream experts providing expression tools and services in biomanufacturing, announced today it has raised $2.7 million in a Series A financing round led by Dynamk Capital as well as... |